In the wake of federal district judges’ recent decisions in drug manufacturers’ 340B contract pharmacy lawsuits, we are keeping close tabs on what happens next to Merck’s contract pharmacy policy and to AstraZeneca’s contract pharmacy lawsuit.
In the wake of federal district judges’ recent decisions in drug manufacturers’ 340B contract pharmacy lawsuits, we are keeping close tabs on what happens next to Merck’s contract pharmacy policy and to AstraZeneca’s contract pharmacy lawsuit.
*Sign up for news summaries and alerts from 340B Report